IL149792A0 - Novel processes for making and a new crystalline form of leflunomide - Google Patents
Novel processes for making and a new crystalline form of leflunomideInfo
- Publication number
- IL149792A0 IL149792A0 IL14979200A IL14979200A IL149792A0 IL 149792 A0 IL149792 A0 IL 149792A0 IL 14979200 A IL14979200 A IL 14979200A IL 14979200 A IL14979200 A IL 14979200A IL 149792 A0 IL149792 A0 IL 149792A0
- Authority
- IL
- Israel
- Prior art keywords
- leflunomide
- making
- crystalline form
- new crystalline
- novel processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17122899P | 1999-12-16 | 1999-12-16 | |
US17123799P | 1999-12-16 | 1999-12-16 | |
US18264700P | 2000-02-15 | 2000-02-15 | |
US20241600P | 2000-05-08 | 2000-05-08 | |
PCT/US2000/033866 WO2001043742A1 (en) | 1999-12-16 | 2000-12-14 | Novel processes for making- and a new crystalline form of- leflunomide |
Publications (1)
Publication Number | Publication Date |
---|---|
IL149792A0 true IL149792A0 (en) | 2002-11-10 |
Family
ID=27496942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14979200A IL149792A0 (en) | 1999-12-16 | 2000-12-14 | Novel processes for making and a new crystalline form of leflunomide |
Country Status (15)
Country | Link |
---|---|
US (3) | US6610718B2 (zh) |
EP (1) | EP1242077A4 (zh) |
JP (1) | JP2003517011A (zh) |
KR (1) | KR20020067545A (zh) |
CN (1) | CN1411373A (zh) |
AU (1) | AU779931B2 (zh) |
CA (1) | CA2397601A1 (zh) |
CZ (1) | CZ20022000A3 (zh) |
HR (2) | HRP20020521A2 (zh) |
HU (1) | HUP0204069A3 (zh) |
IL (1) | IL149792A0 (zh) |
PL (1) | PL356243A1 (zh) |
SK (1) | SK8332002A3 (zh) |
WO (1) | WO2001043742A1 (zh) |
YU (1) | YU45102A (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT903345E (pt) * | 1997-08-08 | 2001-01-31 | Aventis Pharma Gmbh | Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida |
KR20020067545A (ko) * | 1999-12-16 | 2002-08-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노마이드의 신규 제조 방법 및 이의 신규 결정형 |
US20030153585A1 (en) * | 2000-01-13 | 2003-08-14 | Sven-Alexander Schreder | Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary |
ES2237553T3 (es) * | 2000-02-15 | 2005-08-01 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la sintesis de leflunomida. |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
WO2006103506A1 (en) * | 2005-03-31 | 2006-10-05 | Ranbaxy Laboratories Limited | Sertraline-containing pharmaceutical compositions and a process for preparation thereof |
WO2008040149A1 (en) * | 2006-09-05 | 2008-04-10 | Dexian Dou | Composition and method for treating immune-mediated skin disorders |
CN101143834B (zh) * | 2006-09-15 | 2010-09-08 | 欣凯医药化工中间体(上海)有限公司 | N-(4-三氟甲基苯)-2-氰基-3-羟基丁烯酰胺钠盐的多晶型及其制备方法 |
EP2170841A1 (en) | 2007-06-29 | 2010-04-07 | Merck Generics (UK) Limited | Process for introduction of hydroxyethoxy side chain in bosentan |
NZ585438A (en) | 2007-10-24 | 2012-09-28 | Generics Uk Ltd | Novel crystalline forms of 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-pyrimidin-4-yI]-benzenesulfonamide |
CN101939301B (zh) | 2008-02-08 | 2016-07-06 | 基因里克斯(英国)有限公司 | 用于制备波生坦的方法 |
EP2350028A1 (en) | 2008-11-03 | 2011-08-03 | Generics [UK] Limited | Hplc method for the analysis of bosentan and related substances and use of these substances as reference standards and markers |
CN101817797B (zh) * | 2009-02-26 | 2013-04-10 | 江苏亚邦爱普森药业有限公司 | 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法 |
AU2014348523B2 (en) | 2013-11-15 | 2019-01-03 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
US11801232B2 (en) * | 2019-11-27 | 2023-10-31 | Yale University | Targeting of ARID1A-deficient cancers by inhibiting de novo pyrimidine synthesis pathway |
CN112898215B (zh) * | 2021-02-04 | 2022-11-08 | 美罗药业股份有限公司 | 一种来氟米特晶型i的制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
US5494911A (en) * | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
DE19610955A1 (de) * | 1996-03-20 | 1997-09-25 | Hoechst Ag | Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid |
GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
DE19711800A1 (de) * | 1997-03-21 | 1998-09-24 | Hoechst Ag | Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung |
PT903345E (pt) | 1997-08-08 | 2001-01-31 | Aventis Pharma Gmbh | Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida |
EP0933633A1 (en) * | 1997-12-11 | 1999-08-04 | Hoechst Marion Roussel Deutschland GmbH | Process for obtaining L-dihydroorotic acid and use thereof |
US7691890B2 (en) * | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
US6303652B1 (en) * | 1998-08-21 | 2001-10-16 | Hughes Institute | BTK inhibitors and methods for their identification and use |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
DE19908527C2 (de) * | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
PT1196414E (pt) * | 1999-06-25 | 2003-12-31 | Vertex Pharma | Pro-farmacos de inibidores carbamato de impdh |
KR20020067545A (ko) * | 1999-12-16 | 2002-08-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 레플루노마이드의 신규 제조 방법 및 이의 신규 결정형 |
ES2237553T3 (es) * | 2000-02-15 | 2005-08-01 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la sintesis de leflunomida. |
WO2001072298A1 (en) * | 2000-03-27 | 2001-10-04 | The General Hospital Corporation | Treatments for immune-mediated ear disorders |
US20020077485A1 (en) * | 2000-08-14 | 2002-06-20 | Ilya Avrutov | Micronized leflunomide |
JP2004518617A (ja) * | 2000-08-24 | 2004-06-24 | ザ・ユニバーシティ・オブ・テネシー・リサーチ・コーポレーション | 選択的アンドロゲン受容体モジュレーター及びその使用方法 |
JP4212278B2 (ja) * | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
US20040229849A1 (en) * | 2002-09-24 | 2004-11-18 | Jost-Price Edward Roydon | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
CA2535345A1 (en) * | 2003-08-13 | 2005-03-03 | Medtronic, Inc. | Active agent delivery systems including a miscible polymer blend, medical devices, and methods |
CA2535346A1 (en) * | 2003-08-13 | 2005-03-03 | Medtronic, Inc. | Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods |
WO2005023201A2 (en) * | 2003-09-09 | 2005-03-17 | Medarex, Inc. | Methods for treating rheumatoid arthritis |
-
2000
- 2000-12-14 KR KR1020027007575A patent/KR20020067545A/ko not_active Application Discontinuation
- 2000-12-14 CZ CZ20022000A patent/CZ20022000A3/cs unknown
- 2000-12-14 WO PCT/US2000/033866 patent/WO2001043742A1/en not_active Application Discontinuation
- 2000-12-14 IL IL14979200A patent/IL149792A0/xx unknown
- 2000-12-14 CA CA002397601A patent/CA2397601A1/en not_active Abandoned
- 2000-12-14 CN CN00817283A patent/CN1411373A/zh active Pending
- 2000-12-14 EP EP00989253A patent/EP1242077A4/en not_active Withdrawn
- 2000-12-14 AU AU25788/01A patent/AU779931B2/en not_active Ceased
- 2000-12-14 YU YU45102A patent/YU45102A/sh unknown
- 2000-12-14 SK SK833-2002A patent/SK8332002A3/sk unknown
- 2000-12-14 JP JP2001544880A patent/JP2003517011A/ja active Pending
- 2000-12-14 US US09/736,727 patent/US6610718B2/en not_active Expired - Fee Related
- 2000-12-14 PL PL00356243A patent/PL356243A1/xx not_active Application Discontinuation
- 2000-12-14 HU HU0204069A patent/HUP0204069A3/hu unknown
-
2002
- 2002-06-14 HR HR20020521A patent/HRP20020521A2/hr not_active Application Discontinuation
-
2003
- 2003-04-08 US US10/410,493 patent/US6806373B2/en not_active Expired - Fee Related
-
2004
- 2004-07-22 US US10/897,778 patent/US20050004191A1/en not_active Abandoned
-
2005
- 2005-02-23 HR HR20050176A patent/HRP20050176A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HRP20020521A2 (en) | 2004-08-31 |
CZ20022000A3 (cs) | 2003-02-12 |
EP1242077A1 (en) | 2002-09-25 |
US20050004191A1 (en) | 2005-01-06 |
AU779931B2 (en) | 2005-02-17 |
SK8332002A3 (en) | 2003-04-01 |
HUP0204069A3 (en) | 2005-01-28 |
CN1411373A (zh) | 2003-04-16 |
AU2578801A (en) | 2001-06-25 |
US6610718B2 (en) | 2003-08-26 |
EP1242077A4 (en) | 2006-01-04 |
KR20020067545A (ko) | 2002-08-22 |
US20010031878A1 (en) | 2001-10-18 |
HUP0204069A2 (hu) | 2003-04-28 |
HRP20050176A2 (en) | 2005-08-31 |
WO2001043742A1 (en) | 2001-06-21 |
JP2003517011A (ja) | 2003-05-20 |
US20030203952A1 (en) | 2003-10-30 |
US6806373B2 (en) | 2004-10-19 |
CA2397601A1 (en) | 2001-06-21 |
YU45102A (sh) | 2006-01-16 |
PL356243A1 (en) | 2004-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL350828A1 (en) | Method of making a disposable wiper-cloth | |
HK1089447A1 (en) | A process for the preparation of 2-aminocarbonyl-9h-purine derivatives and the intermediates thereof | |
IL149792A0 (en) | Novel processes for making and a new crystalline form of leflunomide | |
HUP0300693A3 (en) | A process for the preparation of epothilone analogs and intermediates | |
HUP0000283A3 (en) | New process for the production of quetiapine | |
GB9929614D0 (en) | Method of manufacturing a transistor | |
SG99351A1 (en) | Process for the manufacture of a crystalline solid | |
IL146972A0 (en) | A substantially crystalline form of melagatran | |
IL139729A0 (en) | A method of adhering ceramic forms | |
HK1052350A1 (zh) | 一種合成嗎啉基苯類化合物的新方法 | |
HU0103554D0 (en) | Method for production of methylene-karbamide polimers | |
HUP9900761A3 (en) | A process for the preparation of 4-(desdimethyl-amino)-tetracyclines | |
AU145473S (en) | A set of buttons | |
ZA200203967B (en) | Novel processes for making- and a new crystalline form of leflunomide. | |
GB2353755B (en) | Method of manufacturing a hollow product | |
AU2001235846A1 (en) | Selective modification of a scheduling process | |
HUP0001408A2 (hu) | Eljárás takarmánymagok előállítására | |
HUP0105421A2 (en) | Shaped part and a method of forming same | |
GB9905586D0 (en) | Method of making a handle | |
GB9926197D0 (en) | Method of manufacturing a structural element | |
GB9909110D0 (en) | Method of forming a can body | |
GB9802487D0 (en) | Production of heptafluoropane | |
PL337562A1 (en) | Method of obtaining a novel 2-methgoxycabamoyl-5-azidocarbonylfurane | |
EG22838A (en) | Process for the preparation of a b-lactam nucleus and application thereof | |
HK1021478A2 (en) | A watch case and a method of making thereof |